GABARAPL2 and acute myeloid leukemia: Moreover, Brigger et al. conducted clinical research demonstrating a notable decrease in the expression of GABARAP family members GABARAPL1 and GABARAPL2/GATE-16 in individuals diagnosed with primary acute myeloid leukemia 216.